1. Home
  2. EDSA vs SOHO Comparison

EDSA vs SOHO Comparison

Compare EDSA & SOHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • SOHO
  • Stock Information
  • Founded
  • EDSA 2015
  • SOHO 2004
  • Country
  • EDSA Canada
  • SOHO United States
  • Employees
  • EDSA N/A
  • SOHO N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • SOHO Real Estate Investment Trusts
  • Sector
  • EDSA Health Care
  • SOHO Real Estate
  • Exchange
  • EDSA Nasdaq
  • SOHO Nasdaq
  • Market Cap
  • EDSA 18.6M
  • SOHO 18.2M
  • IPO Year
  • EDSA N/A
  • SOHO 2004
  • Fundamental
  • Price
  • EDSA $1.73
  • SOHO $2.17
  • Analyst Decision
  • EDSA Strong Buy
  • SOHO
  • Analyst Count
  • EDSA 2
  • SOHO 0
  • Target Price
  • EDSA $13.00
  • SOHO N/A
  • AVG Volume (30 Days)
  • EDSA 908.6K
  • SOHO 863.9K
  • Earning Date
  • EDSA 12-12-2025
  • SOHO 11-13-2025
  • Dividend Yield
  • EDSA N/A
  • SOHO N/A
  • EPS Growth
  • EDSA N/A
  • SOHO N/A
  • EPS
  • EDSA N/A
  • SOHO N/A
  • Revenue
  • EDSA N/A
  • SOHO $180,257,976.00
  • Revenue This Year
  • EDSA N/A
  • SOHO $13.93
  • Revenue Next Year
  • EDSA N/A
  • SOHO N/A
  • P/E Ratio
  • EDSA N/A
  • SOHO N/A
  • Revenue Growth
  • EDSA N/A
  • SOHO 1.07
  • 52 Week Low
  • EDSA $1.55
  • SOHO $0.59
  • 52 Week High
  • EDSA $4.49
  • SOHO $2.18
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 35.70
  • SOHO 88.00
  • Support Level
  • EDSA $1.69
  • SOHO $2.11
  • Resistance Level
  • EDSA $1.83
  • SOHO $2.17
  • Average True Range (ATR)
  • EDSA 0.15
  • SOHO 0.02
  • MACD
  • EDSA -0.01
  • SOHO -0.01
  • Stochastic Oscillator
  • EDSA 17.00
  • SOHO 78.57

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About SOHO Sotherly Hotels Inc.

Sotherly Hotels Inc is engaged in Hotel operations. The company is a self-managed and self-administered lodging real estate investment trust that was formed to own, acquire, renovate, and reposition full-service, upscale, and upper-upscale hotel properties located in primary markets in the mid-Atlantic and southern United States. It generates revenue through the rooms, food, beverage, and other services. Geographically, the group has its presence in the regions of Florida, Georgia, Indiana, Maryland, North Carolina, Pennsylvania, Texas, and Virginia.

Share on Social Networks: